Key Statistics
Market Cap$49.32M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$2.45
52W High$13.69
52W Low$3.76
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees82
Price Performance
1 Week+19.67%
3 Month-5.23%
1 Year+22.99%
FinancialsAnnual · QuiverQuant
Revenue$6.19M
Assets$151.53M
Liabilities$59.45M
Net Income$87.68M loss
About
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing novel therapies to address unmet medical needs in viral and liver diseases. The company is headquartered in South San Francisco, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze ALGS with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.